Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Toyota Global Sales Fall as China Demand Slumps 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Add as a preferred source on Google
NEW YORK, April 04, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) between February 22, 2013 and February 7, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to:
http://www.zlk.com/pslra-d/johnson-johnson?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Johnson & Johnson has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer and mesothelioma; and (2) as a result, Defendants' public statements were materially false and misleading at all relevant times.
If you suffered a loss in Johnson & Johnson you have until April 9, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
